Hsiang-Wen Tseng is Director of Preclinical Development at APRINOIA Therapeutics Inc. The majors and specialties of Hsiang-Wen Tseng are focus on disease animal models for pharmacodynamics evaluation of drug development. In addition, he also developed toxicology studies by preclinical toxicity models and in vitro alternative non-animal methods for cosmetics and chemicals. Hsiang-Wen has been managing the Pharmacodynamics Development and Animal Laboratory in Industrial Technology Research Institute (ITRI), the world’s top R&D institutes for developing and commercializing advanced technologies in Taiwan. He received the Bachelor of Pharmacy at Taipei Medical University and obtained his MS a...
We’ve updated our privacy policy so that we are compliant with changing global privacy regulations and to provide you with insight into the limited ways in which we use your data.
You can read the details below. By accepting, you agree to the updated privacy policy.
